Jackson, Grant Investment Advisers, Inc.
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1650300
STAMFORD, CT
Position in VRTX
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$8,941
+$904 QoQ
Shares Held
18
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,606
of 1,705 holders
Holding Since
Mar 2021
16 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Jackson, Grant Investment Advisers, Inc. holds $175,935 across 4 Biotechnology names. VRTX ranks #2 (5.1% of the industry book) .
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,941 | 18 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $8,037 | 18 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $8,160 | 18 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $7,049 | 18 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $8,013 | 18 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $8,726 | 18 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $7,248 | 18 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $8,371 | 18 | Shares | Sole | 2024-10-17 | |
| 2024-06-30 | $8,436 | 18 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $7,524 | 18 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $7,324 | 18 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $6,259 | 18 | Shares | Sole | 2023-10-13 | |
| 2023-06-30 | $6,334 | 18 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $5,671 | 18 | Shares | Sole | 2023-05-02 | |
| 2021-06-30 | $13,509 | 67 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $24,927 | 116 | Shares | Sole | 2021-04-22 | |
| No filing history on record for this holder in this stock. | ||||||